The signature of breast cancer
Good news for women! Quebec researchers are updating new molecular markers involved in the progression of breast cancer. This signature after the genomic open the door to easy and reliable test that could be done in the future, from a simple blood test!
“These markers allow us to know whether a tumor is present carcinogenic, but also to know its type and aggressiveness,” said Sheriff about Ella, Professor of Microbiology and Infectious Diseases, University of Sherbrook.
To compare breast cancer samples and healthy, the researchers used the new platform RNomics Genome Québec and University de Sherbrook, robotic equipment located in the Functional Genomics Laboratory of the University.
By scanning the RNA – ribonucleic acid, or – to find a specific pattern of disease that researchers have isolated 41 molecular markers linked to breast cancer that affect the functioning and the rate of protein secretion.
The hope cherished researchers would be able to identify good markers to allow detection of proteins in a single incriminating blood. A test is less invasive and even easier!
Breast cancer strikes one in nine women in Canada. More than 430 Canadians each week to learn they have it. Of these, one in four will die from the consequences of the disease.
After the signing of ovarian cancer by the same team discovered early last year, this is another cancer that could be detected more quickly. The results of this study are published in a recent issue of the journal Cancer Research.